Chiron buys Cetus: a tale of two companies.
Gibbons
A
A
D001709:Biotechnology / Q000191:economics*; D007376:Interleukin-2 / Q000235:genetics* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D007376:Interleukin-2; D011994:Recombinant Proteins